Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Health Care Professionals' Perceptions of AI in Clinical Practice: Productivity, Enjoyment, and Pay.
Health Care Professionals' Perceptions of AI in Clinical Practice: Productivity, Enjoyment, and Pay.
Journal: JMIR formative research
Published: December 21, 2025
Patient-reported Itch Outcome Measures for Chronic Pruritus in Dystrophic Epidermolysis Bullosa: Exploratory Analysis of a Phase 2 Randomized Controlled Trial.
Journal: Acta dermato-venereologica
Published: October 30, 2025
Development and Validation of a Scale to Assess Epidermolysis Bullosa Simplex Severity.
Journal: JAMA dermatology
Published: October 15, 2025
Holistic evaluation of large language models for medical tasks with MedHELM.
Journal: Nature medicine
Published: June 03, 2025
Evaluating the appropriateness of skin cancer prevention recommendations obtained from an online chat-based artificial intelligence model.
Journal: JAAD international
Published: January 10, 2025
Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial.
Journal: Lancet (London, England)
Published: January 06, 2025
Atopic dermatitis prevalence among Asian American and Pacific Islander children: A retrospective study in a Northern California health care system.
Journal: Journal of the American Academy of Dermatology
Published: September 25, 2024
DDI-2: A Diverse Skin Condition Image Dataset Representing Self-Identified Asian Patients.
Journal: The Journal of investigative dermatology
Published: August 23, 2024
Single-Lesion Skin Cancer Risk Stratification Triage Pathway.
Journal: JAMA dermatology
Published: June 26, 2024
Parental E-Cigarette Use and Pediatric Atopic Dermatitis.
Journal: JAMA dermatology
Published: May 22, 2024
Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 26, 2024
Last Updated: 09/26/2026